ICR AcademyInstitute for Coherence & Regulation

WP-017 · ICR Core White Paper Series

Standardized Challenge Protocols for Measuring Adaptive Capacity: An Experimental Architecture for Response, Recovery, Reserve, and Repeat-Demand Testing

Standardized challenge protocols

View Zenodo recordDownload original

ICR WHITE PAPER 017

STANDARDIZED CHALLENGE PROTOCOLSFOR MEASURING ADAPTIVE CAPACITY

An Experimental Architecture for Response, Recovery, Reserve, and Repeat-Demand Testing

David Fischer

Institute for Coherence and Regulation (ICR)

Knightdale, North Carolina, USA

September 2026 | Version 2.0

REPLACEMENT PAPER

This paper replaces the former WP-017 Regulatory Load draft. Regulatory Load is governed by WP-011. The retired duplicate should not receive a DOI or be treated as a separate canonical paper.

Abstract

Adaptive Capacity is a dynamic construct: it becomes observable when a defined system is challenged and its response, adjustment, recovery, and retained capability are measured over time. This paper establishes a standardized ICR architecture for low-risk challenge research. It does not prescribe one universal challenge and does not create a clinical stress test. Instead, it defines the minimum methodological features needed to compare response and recovery across studies while preserving domain-specific safety and measurement validity. The core architecture is Baseline → Defined Challenge → Response → Transition → Recovery → Second Matched Challenge. The second challenge is included when scientifically and ethically appropriate because return toward baseline does not necessarily demonstrate restoration of capability.

1. Purpose and Scope

WP-017 operationalizes the dynamic constructs defined elsewhere in the Coherence & Regulation Framework. WP-013 defines Adaptive Capacity; WP-007 defines Recovery Dynamics; WP-006 defines Regulatory Reserve; WP-014 defines Regulatory Efficiency; WP-015 defines Regulatory Thresholds; and WP-016 defines Regulatory Timing. WP-017 specifies how those constructs can be investigated using standardized challenge-response designs.

This is a research-methodology paper. It is not a diagnostic protocol, exercise prescription, medical clearance procedure, treatment algorithm, or authorization for practitioners to expose clients to clinical stressors.

2. Scientific Rationale

Resilience research increasingly treats response to a challenge as a dynamic process that requires repeated measurements. NIH resilience research defines resilience in terms of resisting, adapting to, recovering from, or growing from challenge. Physical-resilience research likewise emphasizes defining the stressor and observing repeated functional or physiological measures over time. ICR adopts that general methodological logic while maintaining separate CRF terminology and testable claims.

The scientific rationale is straightforward: static measurements can describe state, but many CRF constructs concern what happens when demand changes. To study those constructs directly, demand and time must enter the design.

3. Canonical Challenge Architecture

The canonical ICR challenge sequence is:

STABILIZED BASELINE → DEFINED CHALLENGE → RESPONSE → DEMAND TERMINATION OR TRANSITION → RECOVERY → SECOND MATCHED CHALLENGE → SECOND RECOVERY

Not every study requires every phase. A study that omits the second challenge can still measure response and recovery, but it should not claim direct evidence of retained repeat-demand capability.

4. The Second-Challenge Principle

Return toward a baseline value after a first challenge does not necessarily mean that the same functional capability is available again. When safe and scientifically appropriate, a second matched challenge can test whether output, timing, cost, strategy, and recovery are reproducible after the first demand.

The second challenge should be sufficiently comparable to the first that differences can be interpreted. If the challenge itself changes substantially, conclusions about retained capability become weaker.

5. Challenge Selection Criteria

Low enough risk for the population and research setting.

Strong enough to produce a measurable but reversible perturbation in the target domain.

Repeatable or quantifiable enough to support comparison.

Short enough, where possible, to permit adequate recovery observation.

Compatible with validated or defensible outcome measures.

Ethically justified and within the competence and oversight of the research team.

Capable of being stopped immediately when prespecified safety criteria are reached.

A challenge is not valuable merely because it is intense. The objective is informative perturbation, not maximal stress.

6. Candidate Challenge Classes

Candidate research classes may include posture change, standardized walking, submaximal physical activity, simple cognitive tasks, controlled sensory or attentional demand, breathing-related observational tasks, or other validated low-risk perturbations. Selection must be population-specific.

Clinical, invasive, maximal-exertion, ischemic, extreme-temperature, pharmacologic, or otherwise higher-risk provocative tests require appropriate licensed investigators, ethics review, safety infrastructure, and domain-specific standards. Their appearance in the scientific literature does not authorize use in a wellness practice.

7. Stabilized Baseline

Baseline should be long enough and sufficiently standardized to characterize the pre-challenge state. Relevant controls can include posture, recent activity, caffeine, food, sleep, medication timing, room conditions, time of day, device stabilization, and participant acclimation. The variables controlled should match the scientific question.

A single instantaneous baseline reading should not be assumed to represent a stable state when the measured variable naturally fluctuates.

8. Challenge Dose

Challenge dose should be defined using variables appropriate to the task: duration, workload, pace, cognitive complexity, posture, repetition count, environmental condition, or another measurable parameter. The protocol should state whether the dose is fixed, individualized, self-paced, or scaled to baseline capability.

Fixed challenges improve standardization but may impose very different relative demands. Individualized challenges may improve demand matching but require a defensible scaling rule.

9. Response Measurement

Response should be sampled densely enough to characterize the expected dynamics. Candidate features include magnitude, latency, time-to-peak, functional output, strategy, variability, cross-variable coupling, subjective effort, and regulatory cost. No single feature is automatically the primary marker of adaptation.

10. Transition and Demand Termination

The moment the challenge ends or changes should be recorded as an explicit event anchor. Transition behavior can itself be informative: some variables recover immediately, others persist, overshoot, or reorganize. Ambiguous event timing weakens recovery analysis.

11. Recovery Window

Recovery observation should continue long enough to capture the relevant process. The appropriate window depends on the variable and challenge. A protocol should define recovery criteria prospectively where feasible and report participants who do not reach the criterion within the observation window rather than assuming recovery.

12. Repeat-Demand Testing

When a second challenge is used, the recovery interval should be prespecified. Candidate comparisons include first-versus-second functional output, response magnitude, latency, cost, strategy, recovery slope, and time-to-criterion. The second challenge is not a universal requirement and should be omitted when added burden is not justified.

13. Matched-Demand and Matched-Output Logic

Two complementary comparisons are useful. Matched-demand analysis asks how responses differ when the same demand is applied. Matched-output analysis asks what cost or recruitment is required to produce comparable output. Together they help separate capacity, compensation, and efficiency.

14. Minimum Dynamic Dataset

Participant and context descriptors relevant to interpretation.

Baseline state and stabilization conditions.

Precisely defined challenge and dose.

Primary functional output.

At least one response variable sampled at appropriate resolution.

Timing variables or event anchors.

Recovery observations and prespecified recovery window.

Adverse events, stopping criteria, and protocol deviations.

Second-challenge data when retained capability is a study claim.

15. Primary Outcomes

Primary outcomes should be chosen before confirmatory data collection. Suitable outcomes depend on the domain and may include change in function, response amplitude, response latency, recovery slope, time-to-criterion, residual deviation, second-challenge decrement, or another validated dynamic measure. Selecting whichever metric looks most favorable after analysis is exploratory, not confirmatory.

16. Profiles Before Scores

ICR should initially preserve a Challenge-Response Profile rather than compressing all observations into one Adaptive Capacity score. The profile can display demand, output, response, timing, cost, recovery, and repeat-demand capability. Composite scoring requires a separate measurement-development and validation program under WP-009 and WP-023.

17. Standardization Levels

ICR challenge protocols can be classified provisionally as Level A: descriptive/naturalistic challenge; Level B: standardized low-risk challenge; Level C: standardized repeat-demand challenge; and Level D: externally validated domain-specific protocol. These are protocol-development labels, not evidence levels and not clinical severity categories.

18. Reproducibility

A protocol should be documented well enough for another research team to reproduce the challenge, timing, measurements, recovery conditions, and analysis. Device model, software version, calibration or quality-control procedures, sampling frequency, data exclusions, and protocol deviations should be retained where relevant.

19. Safety Architecture

Safety overrides data completeness. Each protocol should define inclusion and exclusion criteria appropriate to the challenge, stopping rules, adverse-event procedures, required supervision, emergency procedures where relevant, and referral or medical-clearance requirements. Low-risk research should still be reviewed for foreseeable burden.

ICR wellness practitioners should not convert this paper into unsupervised clinical stress testing. Research involving human participants must follow applicable ethics, consent, privacy, and institutional requirements.

20. Participant Burden

Repeated challenges can create fatigue, discomfort, learning effects, frustration, or other burden. The number and intensity of trials should be the minimum needed to answer the question. Participant burden is a design variable and an ethical constraint.

21. Learning, Habituation, and Familiarization

Improved second-challenge performance can reflect learning or familiarization rather than restored capacity. Protocols should consider practice trials, counterbalancing, alternate forms, or separate familiarization sessions when those effects are plausible.

22. Carryover

The first challenge can alter the state in which the second challenge occurs. That carryover is partly the phenomenon of interest, but unrelated carryover—hydration, motivation, boredom, pain, thermal accumulation, device drift, or cognitive learning—should be measured or controlled when feasible.

23. Reliability

Before individual change is interpreted, the challenge and its dynamic outcomes should demonstrate adequate repeatability under comparable conditions. Reliability applies to the challenge dose, measurement system, derived metrics, and relevant within-person trajectories.

24. Measurement Error and Smallest Detectable Change

Second-challenge differences smaller than expected measurement error should not be presented as meaningful capacity loss or gain. Where possible, studies should estimate measurement error and establish smallest detectable change for key derived outcomes.

25. Context and Time of Day

Challenge response can depend on circadian phase, recent sleep, meals, medications, activity, emotional state, and environmental conditions. These variables should be standardized, recorded, randomized, or modeled according to their relevance.

26. Five-Layer Measurement

A challenge can produce observations across multiple CRF layers, but the five-layer architecture does not require measuring every layer. Cross-layer claims require direct measures from the layers being discussed. A cardiovascular response cannot by itself establish cellular, endocrine, structural, or meaning-layer change.

27. Cross-Layer Coordination

When synchronized measures are available, studies may examine lagged and context-specific relationships among variables. Stronger synchrony is not automatically better. Appropriate sequencing, inhibition, phase differences, and delayed feedback may be coherent.

28. Regulatory Cost

Cost should be operationalized independently of functional output. Candidate cost measures can include effort, recruitment, physiological excursion, mechanical burden, resource use, or recovery time. The selected measure must be defensible for the domain.

29. Regulatory Reserve

WP-017 does not directly measure an invisible reserve quantity. It can generate evidence relevant to reserve by testing what capability remains after a defined demand. Second-challenge performance is therefore a candidate observable implication of reserve, not a direct meter of reserve itself.

30. Regulatory Thresholds

Progressive challenge designs can identify candidate thresholds, but breakpoint detection must follow WP-015. A safety stopping point, subjective limit, device alarm, or arbitrary workload is not automatically a Regulatory Threshold.

31. Regulatory Drift

One challenge session cannot establish Regulatory Drift. Drift requires longitudinal evidence that matched demands increasingly produce higher cost, altered coordination, slower or incomplete recovery, earlier thresholds, or lower subsequent-demand capability.

32. Modality Firewall

A challenge protocol can be used before and after an intervention, but improvement does not establish a modality-specific mechanism. Reiki, PEMF, structured rest, frequency-based approaches, scalar approaches, red-light exposure, exercise, or another intervention must be evaluated with an appropriate comparator and claim-specific design.

33. Clinical Boundary

These protocols are research tools, not diagnostic tests. They must not be used to diagnose autonomic dysfunction, adrenal dysfunction, mitochondrial dysfunction, inflammatory disease, cardiovascular disease, neurological disease, or other conditions unless a separately validated and authorized clinical test is being used for its established purpose.

34. Statistical Architecture

Dynamic data may require mixed-effects models, functional data analysis, nonlinear models, change-point methods, time-series methods, survival/time-to-event methods, trajectory models, or other approaches. The analysis should follow the hypothesis and data structure rather than forcing every challenge into one ICR formula.

35. Missingness

Missing dynamic observations are often informative: participants may stop because of fatigue, symptoms, device failure, or inability to complete the task. Reasons for missingness should be retained. Complete-case analysis can bias results when noncompletion relates to capacity.

36. Exploratory and Confirmatory Phases

Early protocol development should be exploratory and focus on feasibility, tolerability, signal quality, reliability, and candidate metrics. Confirmatory studies should prespecify the challenge, primary outcomes, recovery criteria, analysis plan, exclusions, and interpretation thresholds.

37. External Validation

A challenge protocol developed within ICR should not be labeled validated until tested in independent data and, ideally, by investigators outside the Institute. Validation should address reproducibility, measurement properties, prediction, responsiveness, and generalizability for the intended population.

38. Incremental Value

The protocol should be compared with simpler established assessments. If a resting measure, standard functional test, validated resilience assessment, or conventional recovery metric provides equivalent useful information, the added challenge complexity may not be justified.

39. Relationship to Existing Resilience Research

NIH and geriatric physical-resilience research already emphasize challenge-response trajectories, repeated measurements, reserve, and recovery. Provocative testing studies have also examined time-based responses to non-harmful challenges. ICR's contribution must therefore be evaluated on whether its integrated demand-response-cost-recovery-repeat-demand architecture produces additional reproducible information, not on the mere use of challenge testing.

40. Current Research Boundary

The standardized challenge architecture proposed here is conceptual and methodological. It has not yet been validated as a whole-person test of CRF Adaptive Capacity. Individual challenge modules must undergo their own feasibility, reliability, validity, safety, and replication work.

41. Falsification Commitments

Retire challenge modules that cannot be administered reproducibly or safely.

Reject dynamic metrics that are dominated by measurement noise.

Abandon second-challenge measures that add no reproducible information beyond baseline and first-recovery measures.

Narrow claims when results are domain-specific rather than whole-person.

Prefer established simpler assessments when they perform equally well.

Revise CRF assumptions when challenge-response findings repeatedly contradict predicted relationships.

Publish or retain null and negative findings rather than selecting only favorable challenge results.

42. Canonical Public Definition

An ICR standardized challenge protocol is a research method that applies or observes a clearly defined, ethically appropriate demand and measures how function changes, how recovery unfolds, and—when appropriate—whether the person can respond comparably again. It is not a diagnosis or a clinical stress test.

43. Recommended Initial Research Sequence

Phase 1 — Select one low-risk, domain-specific challenge and establish feasibility.

Phase 2 — Establish measurement reliability and protocol repeatability.

Phase 3 — Characterize response and recovery trajectories.

Phase 4 — Add a prespecified second matched challenge when justified.

Phase 5 — Test associations with established functional and resilience measures.

Phase 6 — Test predictive and incremental validity prospectively.

Phase 7 — Lock the protocol and externally validate it.

Phase 8 — Seek independent replication before broad institutional claims.

44. Relationship to the ICR Core Series

WP-011 remains the sole canonical Regulatory Load paper. WP-017 now fills the methodological gap between the CRF's dynamic constructs and the experimental designs needed to test them. It should be cross-referenced from WP-006, WP-007, WP-013, WP-015, WP-016, WP-018, WP-023, WP-024, and WP-025 during final series harmonization.

45. Conclusion

Adaptive Capacity cannot be established by a resting snapshot alone when the scientific question concerns response to demand. A defensible research architecture defines the challenge, measures the response, anchors the transition, follows recovery, and—when safe and justified—tests what remains through a second matched demand. The value of the method will depend not on the elegance of the framework but on reproducibility, safety, measurement quality, incremental validity, and independent replication.

Recommended Citation

Fischer, D. (2026). Standardized Challenge Protocols for Measuring Adaptive Capacity: An Experimental Architecture for Response, Recovery, Reserve, and Repeat-Demand Testing. ICR White Paper 017 (Version 2.0). Institute for Coherence and Regulation.

DOI: 10.5281/zenodo.22711700

Selected Scientific References

National Institutes of Health, Office of Dietary Supplements. NIH Resilience Research Working Group: Defining and Conceptualizing Resilience; Resilience Research Design Tool. Accessed September 2026.

Colon-Emeric, C. et al. (2023). Ageing and physical resilience after health stressors. Stress and Health, 39(S1), 48–54. https://doi.org/10.1002/smi.3241

Whitson, H. E. et al. (2016). Physical Resilience in Older Adults: Systematic Review and Development of an Emerging Construct. Journal of Gerontology: Series A, 71(4), 489–495. https://doi.org/10.1093/gerona/glv202

Colón-Emeric, C. S. et al. (2021). A template for physical resilience research in older adults: Methods of the PRIME-KNEE study. Journal of the American Geriatrics Society. PMID 34325481.

A Study of Physical Resilience and Aging (SPRING): Conceptual framework, rationale, and study design. PMID 37386913.

Characterization of Dynamic Adaptation to Stressors Using Multisystem Stimulus-Response Data: The Study of Physical Resilience in Aging Pilot. Published 2025; available through PubMed Central.

Provocative testing in community dwelling older adults: a path to identify physical resilience. Published 2025; available through PubMed Central.

Version Note

Version 2.0 is a replacement paper. The former WP-017 Regulatory Load draft duplicated WP-011 and is retired from the canonical ICR core series. This replacement introduces standardized challenge methodology, formalizes the Second-Challenge Principle as an experimental design option, and preserves the series at 25 unique intended papers pending final audit.